News
CPHI Milan Returns To Fiera Milano And The Lombardy Pharma Region For 2024
CPHI, the world's largest pharmaceutical event – spanning the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging – returns to Fiera Milano (Rho) in 2024, October 8-10.
The global pharma exhibition, organised by Informa, will be...
Drug Research
The Rise of mRNA Technology In Parenteral Drug Manufacturing
The parenteral drug manufacturing process is anchored by the Supply Chain. The impact of COVID-19 has influenced both positively and negatively the production of contemporary parenteral drugs. Many manufacturers have structured their systems around the lean Just-In-Time (JIT) production...
Drug Research
Lonza Launches Nebula Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing
Lonza has launched the Nebula® Absorbance Reader, a new absorbance microplate reader which joins the company’s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.
Pharmaceutical quality control (QC) laboratories worldwide rely on the traditional absorbance-based Limulus amebocyte lysate (LAL) and Tachypleus amebocyte...
News
Green Shift In The Pharmaceutical Industry Through PPWR
The global push towards sustainability is undeniable and is becoming increasingly evident in various aspects of our daily lives, from the vehicles we use to the food we consume. While patient well-being remains the top priority for the pharmaceutical...
News
Circular Healthcare Plastics Approaches For Greener Future
The topic of sustainability in healthcare and medical device packaging involves numerous factors, such as the necessity for sterilized items, specialized waste management, and strict regulations. However, within this intricate landscape, several efforts are being undertaken to enhance the...
News
AI, Automation, And More Reshaping Pharmaceutical Packaging
In the upcoming years of 2023 and beyond, various factors will significantly influence drug development and its associated packaging requirements. These factors include advancements in AI for pharmaceutical manufacturing, the demand for novel injectable dosage forms, and a heightened...
News
The Adderall Shortage: FDA & DEA Seek Increased Production
The FDA and DEA are urging drug manufacturers to ramp up production of prescription stimulants, such as Adderall, due to the ongoing shortage that has lasted almost a year.
They indicated in a joint letter that they are working with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read